Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Recombinant Interferon Variant(PEG-IFN-SA) to Treat HCV Disease (PEG-IFN-SA)

This study has been completed.
Information provided by (Responsible Party):
Yanhua Ding, First Hospital of Jilin University Identifier:
First received: May 10, 2012
Last updated: January 23, 2016
Last verified: January 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)